Pesquisas alternativas:
doses devoid » diet devoid (Expandir a Pesquisa), doses beyond (Expandir a Pesquisa), forms devoid (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa), drugs diet (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
doses devoid » diet devoid (Expandir a Pesquisa), doses beyond (Expandir a Pesquisa), forms devoid (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa), drugs diet (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
1
“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
4
Por Francia, Giulio, Shaked, Yuval, Hashimoto, Kae, Sun, John, Yin, Melissa, Cesta, Carolyn, Xu, Ping, Man, Shan, Hackl, Christina, Stewart, Julie, Uhlik, Mark, Dantzig, Anne H., Foster, Stuart, Kerbel, Robert S.
Publicado em 2011
“... drugs at relatively low minimally toxic doses with no prolonged break periods; it is now showing...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
7
Por Erkılıç, E, Kesimci, E, Alaybeyoğlu, F, Kılınç, I, Tural, R, Yazgan, A, Gümüş, T, Sepici Dinçel, A, Dumlu, EG, Kanbak, O
Publicado no Drug Des Devel Ther (2017)
Obter o texto integralPublicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Artigo
8
“... therapies. Kinases are one of the most common drug targets with a potential for cancer therapy. Cell cycle...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... carcinomas, while drug derivatives devoid of the acetazolamide moiety did not exhibit any detectable...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... potential drug target in lung cancer. However, CDH1 methylation does not correlate with other factors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action
Por Vonderlin, Nadine, Fischer, Fathima, Zitron, Edgar, Seyler, Claudia, Scherer, Daniel, Thomas, Dierk, Katus, Hugo A, Scholz, Eberhard P
Publicado no Drug Des Devel Ther (2015)
“... trafficking, we further found that midazolam does not affect channel surface expression. Taken together, we...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“...) The expression levels of CXCR4 does not increase during local progression, however, CXCR4 expression increases...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Wu, Jianhui, Zhao, Ming, Wang, Yuji, Wang, Yaonan, Zhu, Haimei, Zhao, Shurui, Gui, Lin, Zhang, Xiaoyi, Peng, Shiqi
Publicado no Drug Des Devel Ther (2017)
“... S180 mice, and has a minimal effective dose of 2 nmol/kg per day. At 200 nmol/kg per day, HMCEF does...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
15
Por Apt, Werner
Publicado em 2010
“... in chronic cases, where optical microscopy does not detect parasites. Nifurtimox (NF) and benznidazole (BNZ...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Artigo
16
“... recent clinical trials. The available evidence indicates that this drug does not show unwanted effects...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Coppola, Giangennaro, Iapadre, Giulia, Operto, Francesca Felicia, Verrotti, Alberto
Publicado no Drug Des Devel Ther (2017)
“...Currently, a number of novel anticonvulsant drugs, the so-called third generation, are in various...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Mok, Chi Chiu
Publicado em 2013
“... for the treatment of rheumatoid arthritis (RA) that does not respond adequately to disease-modifying antirheumatic...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... once daily infusion and does not require dose adjustments for renal or moderate hepatic dysfunction...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Cossu, Maria Vittoria, Cattaneo, Dario, Fucile, Serena, Pellegrino, Paolo, Baldelli, Sara, Cozzi, Valeria, Capetti, Amedeo, Clementi, Emilio
Publicado em 2014
“... and to optimize the dosing of the combination of the drugs isosorbide dinitrate, a nitric oxide donor...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo